Andrew Malcolm

Andrew Malcolm is a Senior Scientist specializing in medicinal chemistry at AstraZeneca, with over seven years of experience in drug discovery programs, from Hit ID to candidate selection. Previously, Andrew held positions as a Senior Scientist in Medicinal Chemistry at BenevolentAI and completed a postdoctoral fellowship at The Institute of Cancer Research. Andrew's academic background includes a PhD in Organic Chemistry and an MSci in Chemistry with Drug Discovery, both from the University of Strathclyde. Throughout their career, Andrew has excelled in optimizing compounds, advancing projects, and mentoring junior colleagues.